| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |